However, there was no statistically significant difference in the levels of CD4+CD294+, CD4+CD127+ or CD4+FOXP3+ between the two study groups, although the levels of these chemokines were slightly higher in RA patients compared with healthy controls (p > .05) (Figure 2). The gene discussed is PTGDR2; the disease is rheumatoid arthritis.